Studies on insulin‐resistant animal and cell models have demonstrated that modulating the activity of enzymes associated with m6A modification can ameliorate insulin resistance, offering a potential therapeutic target for diabetes treatment related to insulin resistance [212, 236, 237]. The gene discussed is INS; the disease is diabetes mellitus.